Assenagon Asset Management S.A. Amgen Inc Transaction History

Assenagon Asset Management S.A.

$47.8 Billion
Q3 2024

A detailed history of Assenagon Asset Management S.A. transactions in Amgen Inc stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 1,539,733 shares of AMGN stock, worth $443 Million. This represents 1.04% of its overall portfolio holdings.

Number of Shares

1,539,733

Previous 232,751 561.54%

Holding current value

$443 Million

Previous $72.7 Million 582.2%

% of portfolio

1.04%

Previous 0.19%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$309.38 - $337.38 $404 Million - $441 Million	1,306,982 Added 561.54%	1,539,733 $496 Million
Q2 2024 Jul 18, 2024	SELL	$262.75 - $319.31 $82.8 Million - $101 Million	-314,982 Reduced 57.51%	232,751 $72.7 Million
Q1 2024 Apr 24, 2024	SELL	$268.87 - $324.56 $94.5 Million - $114 Million	-351,499 Reduced 39.09%	547,733 $156 Million
Q4 2023 Jan 17, 2024	BUY	$255.7 - $288.46 $191 Million - $215 Million	745,929 Added 486.57%	899,232 $259 Million
Q3 2023 Nov 06, 2023	BUY	$218.65 - $271.46 $26 Million - $32.3 Million	119,124 Added 348.53%	153,303 $41.2 Million
Q2 2023 Jul 25, 2023	SELL	$214.27 - $253.37 $32.3 Million - $38.2 Million	-150,752 Reduced 81.52%	34,179 $7.59 Million
Q1 2023 Apr 18, 2023	BUY	$225.79 - $275.2 $22.8 Million - $27.8 Million	101,181 Added 120.81%	184,931 $44.7 Million
Q4 2022 Jan 12, 2023	SELL	$229.03 - $291.01 $6.89 Million - $8.76 Million	-30,100 Reduced 26.44%	83,750 $22 Million
Q3 2022 Oct 27, 2022	BUY	$224.46 - $253.15 $24.1 Million - $27.2 Million	107,416 Added 1669.51%	113,850 $25.7 Million
Q2 2022 Jul 27, 2022	SELL	$230.71 - $256.74 $57,908 - $64,441	-251 Reduced 3.75%	6,434 $1.57 Million
Q1 2022 Apr 25, 2022	BUY	$219.27 - $242.57 $10,086 - $11,158	46 Added 0.69%	6,685 $1.62 Million
Q4 2021 Feb 01, 2022	SELL	$198.88 - $227.6 $1.42 Million - $1.63 Million	-7,140 Reduced 51.82%	6,639 $1.49 Million
Q3 2021 Oct 19, 2021	BUY	$212.27 - $248.7 $1.31 Million - $1.54 Million	6,192 Added 81.61%	13,779 $2.93 Million
Q2 2021 Jul 15, 2021	BUY	$233.58 - $259.14 $36,905 - $40,944	158 Added 2.13%	7,587 $1.85 Million
Q1 2021 Apr 26, 2021	SELL	$221.91 - $258.6 $5,325 - $6,206	-24 Reduced 0.32%	7,429 $1.85 Million
Q4 2020 Feb 01, 2021	BUY	$216.38 - $257.67 $511,305 - $608,874	2,363 Added 46.42%	7,453 $1.71 Million
Q3 2020 Oct 07, 2020	SELL	$234.65 - $260.95 $301,994 - $335,842	-1,287 Reduced 20.18%	5,090 $1.29 Million
Q2 2020 Jul 21, 2020	BUY	$197.81 - $242.74 $811,614 - $995,962	4,103 Added 180.43%	6,377 $1.5 Million
Q1 2020 Apr 17, 2020	BUY	$182.24 - $241.7 $414,413 - $549,625	2,274 New	2,274 $461,000
Q4 2019 Jan 17, 2020	SELL	$189.21 - $243.2 $22.3 Million - $28.7 Million	-117,813 Closed	0 $0
Q3 2019 Oct 16, 2019	SELL	$174.11 - $208.62 $59.5 Million - $71.4 Million	-342,018 Reduced 74.38%	117,813 $22.8 Million
Q2 2019 Aug 12, 2019	BUY	$166.7 - $195.41 $64.5 Million - $75.6 Million	387,081 Added 532.07%	459,831 $84.7 Million
Q1 2019 Apr 26, 2019	BUY	$180.87 - $203.88 $3.54 Million - $3.98 Million	19,545 Added 36.74%	72,750 $13.8 Million
Q4 2018 Jan 23, 2019	SELL	$178.4 - $208.25 $36.9 Million - $43 Million	-206,705 Reduced 79.53%	53,205 $10.4 Million
Q3 2018 Oct 29, 2018	SELL	$185.29 - $208.89 $21.9 Million - $24.7 Million	-118,270 Reduced 31.27%	259,910 $53.9 Million
Q2 2018 Jul 17, 2018	BUY	$166.05 - $186.51 $49 Million - $55 Million	294,990 Added 354.6%	378,180 $69.8 Million
Q1 2018 Apr 30, 2018	SELL	$169.43 - $198.0 $3.33 Million - $3.89 Million	-19,647 Reduced 19.1%	83,190 $14.2 Million
Q4 2017 Jan 25, 2018	BUY	$168.79 - $188.59 $4.3 Million - $4.8 Million	25,446 Added 32.88%	102,837 $17.9 Million
Q3 2017 Oct 18, 2017	BUY	$167.29 - $191.0 $12.9 Million - $14.8 Million	77,391	77,391 $14.4 Million

Others Institutions Holding AMGN

# of Institutions

3,121

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Account

Assenagon Asset Management S.A. Amgen Inc Transaction History